Dr. Reddy’s Laboratories files patent for 6-substituted pyridazine compounds for treating diseases dependent on SMARCA2/SMARCA4

Discover how Dr. Reddy's patent for innovative pyridazine compounds offers promising treatments for diseases dependent on SMARCA2 and SMARCA4 proteins, including various cancers. Explore detailed chemical structures and potential therapeutic benefits.

Related Posts

STAT+: Pharmalittle: Lilly wins FDA approval for a weig...

Nov 9, 2023

Star Therapeutics raises $90m in funding to advance ant...

Sep 5, 2023

STAT+: Biogen shutters digital health group, nixes Appl...

Sep 28, 2023